A Phase I Trial of Regorafenib and Cetuximab in Patients With Solid tumors.

Trial Profile

A Phase I Trial of Regorafenib and Cetuximab in Patients With Solid tumors.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jan 2016

At a glance

  • Drugs Cetuximab (Primary) ; Regorafenib (Primary)
  • Indications Colorectal cancer; Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 08 Jan 2016 New trial record
    • 09 Nov 2015 Results presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top